A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol

Peer Review reports

Original Submission
24 May 2018	Submitted	Original manuscript
30 Aug 2018	Reviewed	Reviewer Report - Claudia Pedroza
24 Sep 2018	Author responded	Author comments - James May
Resubmission - Version 2
24 Sep 2018	Submitted	Manuscript version 2
Publishing
20 Oct 2018	Editorially accepted
20 Nov 2018	Article published	10.1186/s13063-018-3008-6

Back to article page